Skip to main content
Caplight Logo









SpectraMedix

SpectraMedix

Private
East Windsor, ConnecticutHealthcare & Life Scienceshttps://www.spectramedix.com/

Last Round

Accelerator

Oct 15, 2012

Total Funding Raised

$300,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

SpectraMedix is a health tech company that provides a modular analytics platform designed for optimizing healthcare operations and managing value-based care contracts.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Business Intelligence, Vertical SaaS, Compliance & Risk, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

value-based careVBChealthcare analyticsvalue-based paymentpopulation health managementpop healthAccountable Care OrganizationACOrisk adjustmenthealth plan analyticsVBP contract modelingmedical AIrisk stratificationcontract settlementSocial Determinants of HealthSDoH

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SpectraMedix Comparables

Compare SpectraMedix with similar companies based on industry and business-model similarity.

SpectraMedix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lightbeam Health Solutions
85%
Persivia
84%
MedeAnalytics
79%

SpectraMedix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 15, 2012

Key People

Founding team and executive leadership

Raj Lakhanpal

Chief Executive Officer

Executive Team

SpectraMedix Investors

Notable investors and investment history

SpectraMedix investors
InvestorRounds
New York Digital Health AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Web traffic grew 49% MoM (from 3.1K to 4.6K monthly visitors)

  • Jun 23, 2026

    Monthly visitors increased 40% MoM.

SpectraMedix Filings

Explore SEC and related filing metadata, where available.

SpectraMedix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SpectraMedix's valuation, stock price, and market status.

Is SpectraMedix a public or private company?

SpectraMedix is a private company.

What is the current stock price of SpectraMedix?

SpectraMedix is a private company with no public stock price. No recent secondary market data is available.

How much is SpectraMedix worth (valuation)?

Valuation information for SpectraMedix is not publicly available.

Can I buy SpectraMedix stock?

SpectraMedix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SpectraMedix's last funding round?

Funding round information for SpectraMedix is not publicly available.

Who are the main investors in SpectraMedix?

Investor information for SpectraMedix is not publicly disclosed.

Will SpectraMedix IPO soon?

No public IPO plans have been announced for SpectraMedix.

How can I track SpectraMedix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SpectraMedix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEast Windsor, Connecticut
Employee Range157
Year Founded2009
Last FundingOct 15, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?